Our data suggest that CCN2 is not a key driver of myelofibrosis in MPN, and that noncanonical, CCN2 independent, rather than canonical TGF-β signaling might be responsible for the development of fibrosis in MPN. The gene discussed is CCN2; the disease is myeloproliferative disorder.